OPKO HEALTH INC
Aktie · US68375N1037 · OPK · A0MUUJ (XNAS)
1,38 USD
06.06.2025 19:18
Aktuelle Kurse von OPKO HEALTH INC
Börse | Ticker | Währung | Letzter Umsatz | Kurs | Tagesveränderung |
---|---|---|---|---|---|
![]() NASDAQ |
OPK
|
USD
|
06.06.2025 19:18
|
1,38 USD
| 1,37 USD
+0,36 %
|
![]() London |
0KCS.L
|
USD
|
06.06.2025 14:16
|
1,37 USD
| 1,37 USD
+0,04 %
|
Performance
Heute | Woche | Monat | 3 Monate | 6 Monate | 1 Jahr | 5 Jahre |
---|---|---|---|---|---|---|
0,36 % | 1,10 % | 1,10 % | -29,12 % | -11,83 % | -0,36 % | -41,49 % |
Firmenprofil zu OPKO HEALTH INC Aktie
OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health, and correctional healthcare to physician offices, clinics, hospitals, employers and governmental units; and a novel diagnostic instrument system to provide blood test results in the point-of-care setting, as well as 4Kscore prostate cancer testing services. Its Pharmaceutical segment offers Rayaldee to treat secondary hyperparathyroidism in adults with stage 3 or 4 chronic kidney disease, and vitamin D insufficiency; OPK88004, an orally administered selective androgen receptor modulator; OPK88003, a once-weekly administered peptide for the treatment of type 2 diabetes and associated obesity that is in Phase IIb trials; and hGH-CTP, a once-weekly human growth hormone injection that completed Phase III clinical trial in partnership with Pfizer, Inc. This segment develops and commercializes longer-acting proprietary versions of already approved therapeutic proteins. The company also offers specialty APIs; develops, manufactures, markets, and sells pharmaceutical, nutraceutical, veterinary, and ophthalmic products; commercializes food supplements and over the counter products; manufactures and sells products primarily in the generics market; and imports, markets, distributes, and sells pharmaceutical products in a range of indications, including cardiovascular products, vaccines, antibiotics, gastro-intestinal products, hormones, and others. In addition, it operates pharmaceutical platforms in Ireland, Chile, Spain, and Mexico. The company was founded in 1991 and is headquartered in Miami, Florida.
Unternehmensdaten
Name OPKO HEALTH INC
Firma OPKO Health, Inc.
Symbol OPK
Website
https://www.opko.com
Heimatbörse
NASDAQ

WKN A0MUUJ
ISIN US68375N1037
Wertpapierart Aktie
Sektor Healthcare
Branche Medical - Pharmaceuticals
CEO Dr. Phillip Frost Ph.D.
Marktkapitalisierung 960 Mio
Land Vereinigte Staaten von Amerika
Währung USD
Mitarbeiter 3,0 T
Adresse 4400 Biscayne Boulevard, 33137 Miami
IPO Datum 2018-01-29
Kennungs-Wechsel
Datum | Von | Zu |
---|---|---|
13.06.2007 | EXEG | OPK |
Ticker Symbole
Name | Symbol |
---|---|
Frankfurt | XCY.F |
London | 0KCS.L |
NASDAQ | OPK |
Weitere Aktien
Investoren die OPKO HEALTH INC die halten, haben auch folgende Aktien im Depot:
Die Finanzplattform MoneyPeak trackt und analysiert Investitionen und Portfolios.
Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.